|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00557 TIANYUAN HEALTH
Nominal 
0.800 0.000 (0.000%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 26,845 | -40.648% | 45,230 | 54,216 | 94,588 | 56,340 |
| Cost of Sales | (5,607) | -67.561% | (17,285) | (19,391) | (23,281) | (18,766) |
| Gross Profit | 21,238 | -24.001% | 27,945 | 34,825 | 71,307 | 37,574 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (23,473) | -- | -- | -- | -- | 3,240 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | 2,497 | -- | (10,013) | (800) | 1,299 | -- | |
| Share of Results of Asso. & JCEs | (14) | -96.164% | (365) | 242 | 184 | 549 | |
| Profit / (Loss) before Taxation | (38,429) | 33.536% | (28,778) | (40,349) | (19,063) | (125,847) | |
| Taxation | (177) | -- | 1,821 | 0 | 0 | 15,812 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,368 | -61.928% | 11,473 | 11,313 | 2,209 | 44,934 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (34,238) | 121.119% | (15,484) | (29,036) | (16,854) | (65,101) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 2,479 | -26.895% | 3,391 | 3,931 | 4,480 | 2,421 |
| Depreciation & Amortisation | 7,979 | -12.087% | 9,076 | 9,529 | 11,869 | 21,142 |
| Directors' Emoluments | 1,049 | -4.113% | 1,094 | 5,639 | 9,012 | 10,020 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -8.580 | 121.134% | -3.880 | -7.280 | -4.220 | -16.310 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.013 | (0.076) | 0.041 | 0.132 |
| NBV per share ($) | 0.488 | -- | 0.577 | 0.562 | 0.642 | 0.671 |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -34,238,000 |
| %Change | 121.119% |
| EPS / (LPS) | HKD -0.086 |
| NBV Per Share ($) | HKD 0.488 |